Company: SMNR
Filing Date: 2025-08-22
Form Type: 425
Source: 0001213900-25-079506
Chunk: 0

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: 425
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 20, 2025

DENALI CAPITAL ACQUISITION CORP.

(Exact name of registrant as specified in its charter)</div>

| Cayman  Islands              |     | 001-41351               |     | 98-1659463         |
| (State or other jurisdiction 
 of incorporation)            |     | -Commission File Number |     | -I.R.S. Employer   
 Identification No. |

| 437 Madison Avenue              
 27th Floor                      
 New York, New York              |     | 10022 |
| (Address                        
 of principal executive offices) |     |  -Zip 
  Code |

<div align='center'>Registrant’s telephone number, including area code: (646) 978-5180

Not Applicable

(Former name or former address, if changed since last report)</div>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

| ☒ | Written communication pursuant                        
 to Rule 425 under the Securities Act (17 CFR 230.425) |

| ☐ | Soliciting material pursuant                              
 to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |

| ☐ | Pre-commencement communications                                        
 pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |

| ☐ | Pre-commencements communications                                       
 pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

| Title                                                                                                  
 of each class                                                                                          |     | Trading   
 Symbol(s) |     | Name                
 of each exchange    
 on which registered |
| Units,                                                                                                 
 each consisting of one Class A ordinary share and one redeemable warrant                               |     | DNQUF     |     | Pink                
 Current             |
| Class                                                                                                  
 A ordinary shares, par value $0.0001 per share